Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5292]

Molecule secreted by cancer-associated fibroblasts promotes anticancer drug resistance

Molecule secreted by cancer-associated fibroblasts promotes anticancer drug resistance

A metabolic enzyme as a potential new target for cancer immune therapies

A metabolic enzyme as a potential new target for cancer immune therapies

FDA grants priority review to trilaciclib for the treatment of small cell lung cancer

FDA grants priority review to trilaciclib for the treatment of small cell lung cancer

Observational study shows tocilizumab improves survival in sickest COVID-19 patients

Observational study shows tocilizumab improves survival in sickest COVID-19 patients

Blocking copper uptake in tumour cells may be clue to boosting immune system

Blocking copper uptake in tumour cells may be clue to boosting immune system

Acidic niche keeps lymphatic system in check during immune response

Acidic niche keeps lymphatic system in check during immune response

Drugs against alpha-ketoglutarate may combat deadly childhood brain tumour

Drugs against alpha-ketoglutarate may combat deadly childhood brain tumour

Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations

Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations

Potency-enhancing drugs linked to decreased risks in men with colorectal cancer

Potency-enhancing drugs linked to decreased risks in men with colorectal cancer

PARP inhibitor rucaparib becomes new treatment option for some men with advanced prostate cancer

PARP inhibitor rucaparib becomes new treatment option for some men with advanced prostate cancer

More from ecancer